Title : Proteasome inhibitors reduce thrombospondin-1 release in human dysferlin-deficient myotubes.

Pub. Date : 2020 Nov 27

PMID : 33246442






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Treatment with proteasome inhibitors and EB1089 resulted in a trend towards an increase in dysferlin and myogenin expression. seocalcitol myogenin Homo sapiens